58-year-old woman with pancreatic neuroendocrine tumour
Journal Title: OncoReview - Year 2014, Vol 4, Issue 2
Abstract
We reported a 58-year-old woman with tumor in the tail and body of pancreas measuring 70 mm in diameter who underwent distal pancreatectomy and splenectomy. Examination of a specimen of the pancreatic mass obtained histopathological features of a well-differentiated neuroendocrine carcinoma (WHO 2000 r. NECLM group 2, MIB < 2%). Immunohistochemical staining showed that the tumor cells were positive for chromogranin and synaptophysin. The tumor was radical resected; there were 9 lymph nodes without metastases. The patient was attending routine follow-up 3 years after resection, when ultrasonography detected hepatic tumor with a low echoic area, confirmed as at least 3 lesions in CT. The patient presented with symptoms of general malaise, anorexia, weight loss, diarrhea, and diabetes mellitus. The diagnosis including of the histopathological features resected specimen and symptoms suggested a somatostatinoma. The patient denied the surgery treatment so she was treated with good clinical and biochemical (normalization of chromogranin A) response to octreotide LAR. During follow-up 4 months after, Computer Tomography showed progression. The patient refused suggested chemotherapy streptozotocin combined with doxorubicin. We continued treatment with octreotide LAR, taking into consideration lack of symptoms and stabilization in chromogranin A level, with good result and stabilization in following Computer Tomography.Somatostatinoma originates from delta cells and is a rare neoplasm, accounting for about 1% of gastroenteropancreatic endocrine neoplasms. About half of somatostatinomas originate in the pancreas, and the remainders originate in other parts of the gastrointestinal tract, mainly in the duodenum. Measurement of the plasma somatostatin concentration is useful for making a diagnosis of somatostatinoma, however is very difficult to perform this examination in our country. Successful treatment with long-acting somatostatin analogues (octreotide LAR) has been reported after progression
Authors and Affiliations
Agnieszka Kolasińska-Ćwikła
Keywords
Related Articles
- EP ID EP67756
- DOI -
- Views 224
- Downloads 0
The role of vena cava inferior filters in the prevention of venous thromboembolism prior to oncological surgeries
Venous thromboembolism represents one of the most important causes of complications and mortality in cancer patients. The therapy in this group of patients is mainly focused on adequate anticoagulant prophylaxis. In diff...
Wczesna odpowiedź molekularna jako kryterium optymalnej odpowiedzi na leczenie przewlekłej białaczki szpikowej inhibitorami kinaz tyrozynowych
Obecnym celem leczenia przewlekłej białaczki szpikowej jest maksymalna redukcja liczby komórek białaczkowych z genem BCR/ABL i umożliwienie jak największej liczbie chorych osiągnięcia długotrwałej, głębokiej odpowiedzi m...
Nowe dane dotyczące leczenia pacjentów z nowotworami układu moczowo-płciowego prezentowane w trakcie corocznego zjazdu American Society of Clinical Oncology w 2011 r.
WSTĘP: W dniach 3.06.2011–06.06.2011 r. w Chicago (USA) odbył się coroczny zjazd ASCO (American Society of Clinical Oncology).MATERIAŁ I METODY: Materiał omówiono z podziałem na zagadnienia dotyczące nowotworów zarodkowy...
Paraneoplastic neurological syndrome in the course of breast cancer
Paraneoplastic neurological syndromes (PNS) are a group of rarely observed disorders, accompanying about 1% of cancer diseases. They have a typically aggressive course, leading to profound and essentially irreversible di...
Advanced or metastatic non-small-cell lung cancer treatment - new Polish goverment regulation
The article presents the non-small-cell lung cancer current treatment recommendations in consideration of Polish government regulation.